Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0000902664-24-005221
Filing Date
2024-08-20
Accepted
2024-08-20 16:15:35
Documents
2

Document Format Files

Seq Description Document Type Size
1 BIORA THERAPEUTICS, INC. p24-2620sc13g.htm SC 13G 91577
2 JOINT FILING AGREEMENT p24-2620exhibit99.htm EX-99.1 3043
  Complete submission text file 0000902664-24-005221.txt   96526
Mailing Address 4330 LA JOLLA VILLAGE DRIVE SUITE 200 SAN DIEGO CA 92122
Business Address 4330 LA JOLLA VILLAGE DRIVE SUITE 200 SAN DIEGO CA 92122 855-293-2639
BIORA THERAPEUTICS, INC. (Subject) CIK: 0001580063 (see all company filings)

EIN.: 273950390 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-91551 | Film No.: 241225323
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 520 MADISON AVENUE 30TH FLOOR NEW YORK NY 10022
Business Address 520 MADISON AVENUE 30TH FLOOR NEW YORK NY 10022 212-446-4000
DAVIDSON KEMPNER CAPITAL MANAGEMENT LP (Filed by) CIK: 0001595082 (see all company filings)

EIN.: 133863161 | State of Incorp.: DE
Type: SC 13G